Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy

참고문헌 (5)

1. El Khoury AC, "Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas", J Med Econ, 15, pp.887~896 (2012)
2. Jeong SH, "Current status of hepatitis C virus infection and countermeasures in South Korea", Epidemiol Health, 39, pp.e2017017~ (2017)
3. Rein DB, "The burden of hepatitis C to the United States Medicare system in 2009: descriptive and economic characteristics", Hepatology, 63, pp.1135~1144 (2016)
4. 기모란, "Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims’ Data", Gut and Liver, 11(6), pp.835~842 (2017), 거트앤리버 발행위원회
5. Kim DY, "Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea", Medicine (Baltimore), 95, pp.e3896~ (2016)

관련 논문AI추천